X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (200) 200
index medicus (145) 145
female (105) 105
male (104) 104
urology & nephrology (91) 91
complement (85) 85
hemolytic-uremic syndrome (75) 75
adult (71) 71
immunology (65) 65
child (60) 60
mutation (54) 54
hemolytic-uremic syndrome - genetics (52) 52
mutations (51) 51
life sciences (46) 46
middle aged (45) 45
adolescent (44) 44
child, preschool (41) 41
complement factor h - genetics (41) 41
eculizumab (41) 41
atypical hemolytic uremic syndrome (40) 40
membrane cofactor protein (37) 37
activation (35) 35
infant (34) 34
factor-i (31) 31
treatment outcome (30) 30
alternative pathway (29) 29
glomerulonephritis (29) 29
hemolytic uremic syndrome (29) 29
complement factor-h (28) 28
hemolytic-uremic syndrome - immunology (28) 28
risk factors (28) 28
transplantation (28) 28
young adult (28) 28
factor-h (27) 27
membranoproliferative glomerulonephritis (27) 27
aged (26) 26
nephrology (26) 26
thrombotic thrombocytopenic purpura (26) 26
genetic predisposition to disease (25) 25
membrane cofactor protein - genetics (25) 25
abridged index medicus (24) 24
hematology (24) 24
research (24) 24
complement activation (23) 23
human health and pathology (23) 23
pediatrics (23) 23
deficiency (22) 22
dense deposit disease (22) 22
disease (22) 22
gene (22) 22
kidney transplantation (22) 22
thrombotic microangiopathy (21) 21
antibodies, monoclonal, humanized - therapeutic use (20) 20
children (20) 20
complement c3 - metabolism (20) 20
complement factor h - immunology (20) 20
urologic and male genital diseases (20) 20
autoantibodies (19) 19
complement system proteins - genetics (19) 19
pedigree (19) 19
genetic aspects (18) 18
hemolytic-uremic syndrome - therapy (18) 18
retrospective studies (18) 18
complement factor h (17) 17
heterozygote (17) 17
medical and health sciences (17) 17
medicin och hälsovetenskap (17) 17
medicine & public health (17) 17
plasma exchange (17) 17
recurrence (17) 17
animals (16) 16
complement c3 - genetics (16) 16
endothelial-cells (16) 16
glomerulonephritis, membranoproliferative - genetics (16) 16
hemic and lymphatic diseases (16) 16
biochemistry & molecular biology (15) 15
care and treatment (15) 15
glomerulonephritis, membranoproliferative - pathology (15) 15
hemolytic-uremic syndrome - diagnosis (15) 15
cohort studies (14) 14
complement factor i - genetics (14) 14
glomerulonephritis, membranoproliferative - immunology (14) 14
impact (14) 14
medicine, general & internal (14) 14
prognosis (14) 14
complement pathway, alternative - genetics (13) 13
dna mutational analysis (13) 13
factor h (13) 13
factor i (13) 13
follow-up studies (13) 13
hemolytic-uremic syndrome - complications (13) 13
hemolytic-uremic syndrome - drug therapy (13) 13
phenotype (13) 13
atypical hemolytic uremic syndrome - genetics (12) 12
c3 glomerulopathy (12) 12
complement c3 - analysis (12) 12
complement system proteins - immunology (12) 12
diagnosis (12) 12
kidney - pathology (12) 12
pregnancy (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Genetics, ISSN 1061-4036, 05/2013, Volume 45, Issue 5, pp. 531 - 536
Journal Article
Orphanet Journal of Rare Diseases, ISSN 1750-1172, 2011, Volume 6, Issue 1, pp. 60 - 60
Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical hemolytic anemia, thrombocytopenia and renal impairment. Atypical HUS (aHUS) defines non... 
Plasma exchange | Factor H | Combined liver-kidney transplantation | Plasma infusion | Factor B | Atypical hemolytic uremic syndrome | Eculizumab | Membrane cofactor protein | Thrombomodulin | Factor I | Kidney transplantation | MEDICINE, RESEARCH & EXPERIMENTAL | factor I | CFHR1/CFHR3 DEFICIENCY | LIVER-KIDNEY TRANSPLANTATION | plasma infusion | kidney transplantation | eculizumab | factor B | THROMBOTIC THROMBOCYTOPENIC PURPURA | SUCCESSFUL RENAL-TRANSPLANTATION | factor H | combined liver-kidney transplantation | INHIBITOR ECULIZUMAB | ALTERNATIVE PATHWAY | membrane cofactor protein | thrombomodulin | GENETICS & HEREDITY | plasma exchange | SUCCESSFUL PLASMA THERAPY | FACTOR-I MUTATIONS | COMPLEMENT-FACTOR-H | Complement Activation | Humans | Middle Aged | Child, Preschool | Complement System Proteins - immunology | Infant | Male | Hemolytic-Uremic Syndrome - epidemiology | Young Adult | Hemolytic-Uremic Syndrome - genetics | Hemolytic-Uremic Syndrome - physiopathology | Aged, 80 and over | Adult | Complement System Proteins - genetics | Female | Hemolytic-Uremic Syndrome - therapy | Child | Infant, Newborn | Risk Factors | Kidney Transplantation | Animals | Adolescent | Aged | Mice | Mutation | Atypical Hemolytic Uremic Syndrome | Viral antibodies | Usage | Care and treatment | Antibodies | Genetic aspects | Research | Diagnosis | Health aspects | Genetic screening | Hemolytic-uremic syndrome | Risk factors | Lupus | Plasma | E coli | Disease | Vascular endothelial growth factor | Streptococcus infections
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 08/2012, Volume 82, Issue 4, pp. 454 - 464
Dense deposit disease and glomerulonephritis with isolated C3 deposits are glomerulopathies characterized by deposits of C3 within or along the glomerular... 
complement | glomerulonephritis | clinical immunology | membranoproliferative glomerulonephritis (MPGN) | LONG-TERM | HEMOLYTIC-UREMIC SYNDROME | MESANGIOCAPILLARY GLOMERULONEPHRITIS | GLOMERULONEPHRITIS TYPE-II | MACULAR DEGENERATION | FACTOR-H DEFICIENCY | GLOMERULAR-FILTRATION-RATE | UROLOGY & NEPHROLOGY | MUTATIONS | MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS | MEMBRANE COFACTOR PROTEIN | Humans | Child, Preschool | Male | Complement System Proteins - metabolism | Young Adult | Time Factors | DNA Mutational Analysis | Renal Insufficiency - immunology | Child | Glomerulonephritis, Membranoproliferative - pathology | Genetic Predisposition to Disease | Risk Assessment | Complement C3 - metabolism | Gene Frequency | Risk Factors | Glomerulonephritis - genetics | Glomerulonephritis - immunology | Glomerulonephritis - mortality | Biomarkers - blood | Kidney Glomerulus - pathology | Disease Progression | Glomerulonephritis, Membranoproliferative - genetics | Glomerulonephritis, Membranoproliferative - immunology | Phenotype | Complement Factor H - metabolism | Glomerulonephritis, Membranoproliferative - mortality | Glomerulonephritis - pathology | Adolescent | Age of Onset | Membrane Cofactor Protein - genetics | Kidney Glomerulus - immunology | Mutation | Complement Factor I - metabolism | Haplotypes | Complement C3 Nephritic Factor - genetics | Glomerulonephritis - therapy | Infant | Case-Control Studies | Adult | Complement System Proteins - genetics | Female | Membrane Cofactor Protein - metabolism | Complement Pathway, Alternative - genetics | France | Renal Insufficiency - genetics | Kaplan-Meier Estimate | Complement Factor I - genetics | Treatment Outcome | Chi-Square Distribution | Glomerulonephritis, Membranoproliferative - therapy | Biopsy | Complement C3 Nephritic Factor - metabolism | Complement Factor H - genetics
Journal Article
Kidney International, ISSN 0085-2538, 12/2013, Volume 84, Issue 6, pp. 1079 - 1089
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2013, Volume 63, Issue 1, pp. 40 - 48
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 02/2015, Volume 67, Issue 2, pp. 527 - 534
Journal Article